Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HepQuant: Pilot Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer

NCT06899152 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT06899152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06899152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HepQuant: Pilot Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Lead sponsor
Montefiore Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
July 16, 2025
Completion date
July 31, 2031
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, hepatocellular cancer, hepatocellular carcinoma, liver cancer, liver metastases